Skip to main content

Prudentia Sciences

Cambridge, United States

Prudentia Sciences is a platform enables AI-powered Asset Diligence and Valuation to De-Risk Investment in Drug Development.

$20.0M raised
Jan 2026
Series A

Top Investors

VirtueSignalFireGoogle VenturesMcKesson VenturesIaso Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Prudentia Sciences

How much funding has Prudentia Sciences raised?
Prudentia Sciences has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Who are Prudentia Sciences's investors?
Prudentia Sciences's investors include Virtue, SignalFire, Google Ventures, McKesson Ventures, Iaso Ventures.
Where is Prudentia Sciences headquartered?
Prudentia Sciences is headquartered in Cambridge, United States.
What does Prudentia Sciences do?
Prudentia Sciences is a platform enables AI-powered Asset Diligence and Valuation to De-Risk Investment in Drug Development.
What stage is Prudentia Sciences at?
Prudentia Sciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Prudentia Sciences — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/prudentia-sciences. Accessed June 3, 2026.
APA
VCBacked. (2026). Prudentia Sciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/prudentia-sciences
Wikipedia (cite web)
{{cite web |title=Prudentia Sciences — Funding & Investors |url=https://www.vcbacked.co/company/prudentia-sciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .